Probi AB (publ) Logo

Probi AB (publ)

0GZB.L

(0.0)
Stock Price

203,00 SEK

-0.07% ROA

-0.04% ROE

-3842.22x PER

Market Cap.

2.313.002.300,00 SEK

2.59% DER

0% Yield

-0.1% NPM

Probi AB (publ) Stock Analysis

Probi AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Probi AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Probi AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Probi AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Unknown
2 MACD Unknown
3 RSI Unknown
4 Stoch RSI Unknown

Probi AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Probi AB (publ) Revenue
Year Revenue Growth
2012 100.392.000
2013 103.554.000 3.05%
2014 135.242.000 23.43%
2015 215.981.000 37.38%
2016 443.475.000 51.3%
2017 612.244.000 27.57%
2018 604.117.000 -1.35%
2019 626.192.000 3.53%
2020 717.165.000 12.69%
2021 658.180.000 -8.96%
2022 618.285.000 -6.45%
2023 624.120.000 0.93%
2023 627.687.000 0.57%
2024 606.696.000 -3.46%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Probi AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2012 18.690.000
2013 19.484.000 4.08%
2014 21.717.000 10.28%
2015 30.616.000 29.07%
2016 51.033.000 40.01%
2017 40.652.000 -25.54%
2018 36.890.000 -10.2%
2019 37.497.000 1.62%
2020 45.630.000 17.82%
2021 47.396.000 3.73%
2022 48.273.000 1.82%
2023 30.616.000 -57.67%
2023 44.601.000 31.36%
2024 42.960.000 -3.82%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Probi AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 18.743.000 100%
2016 48.036.000 60.98%
2017 58.554.000 17.96%
2018 54.700.000 -7.05%
2019 45.989.000 -18.94%
2020 54.525.000 15.66%
2021 54.443.000 -0.15%
2022 65.909.000 17.4%
2023 55.072.000 -19.68%
2023 58.587.000 6%
2024 60.536.000 3.22%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Probi AB (publ) EBITDA
Year EBITDA Growth
2012 23.143.000
2013 20.887.000 -10.8%
2014 31.297.000 33.26%
2015 61.688.000 49.27%
2016 149.491.000 58.73%
2017 153.272.000 2.47%
2018 150.775.000 -1.66%
2019 162.783.000 7.38%
2020 176.380.000 7.71%
2021 161.993.000 -8.88%
2022 114.498.000 -41.48%
2023 112.680.000 -1.61%
2023 83.927.000 -34.26%
2024 88.024.000 4.65%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Probi AB (publ) Gross Profit
Year Gross Profit Growth
2012 81.915.000
2013 77.762.000 -5.34%
2014 93.565.000 16.89%
2015 147.967.000 36.77%
2016 270.485.000 45.3%
2017 277.923.000 2.68%
2018 278.030.000 0.04%
2019 291.646.000 4.67%
2020 309.957.000 5.91%
2021 288.007.000 -7.62%
2022 255.445.000 -12.75%
2023 204.916.000 -24.66%
2023 220.213.000 6.95%
2024 198.368.000 -11.01%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Probi AB (publ) Net Profit
Year Net Profit Growth
2012 13.505.000
2013 15.045.000 10.24%
2014 21.765.000 30.88%
2015 49.039.000 55.62%
2016 101.847.000 51.85%
2017 69.092.000 -47.41%
2018 76.250.000 9.39%
2019 85.887.000 11.22%
2020 92.693.000 7.34%
2021 83.145.000 -11.48%
2022 40.622.000 -104.68%
2023 25.580.000 -58.8%
2023 16.819.000 -52.09%
2024 7.412.000 -126.92%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Probi AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 1
2013 2 0%
2014 2 50%
2015 5 60%
2016 11 50%
2017 6 -66.67%
2018 7 0%
2019 8 14.29%
2020 8 12.5%
2021 7 -14.29%
2022 4 -133.33%
2023 2 -50%
2023 1 -100%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Probi AB (publ) Free Cashflow
Year Free Cashflow Growth
2012 23.099.000
2013 24.225.000 4.65%
2014 33.410.000 27.49%
2015 60.848.000 45.09%
2016 87.715.001 30.63%
2017 137.517.001 36.22%
2018 124.064.000 -10.84%
2019 146.880.000 15.53%
2020 113.328.000 -29.61%
2021 119.048.000 4.8%
2022 103.665.000 -14.84%
2023 9.783.000 -959.64%
2023 52.388.001 81.33%
2024 13.782.000 -280.12%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Probi AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2012 24.201.000
2013 24.696.000 2%
2014 37.233.000 33.67%
2015 62.086.000 40.03%
2016 89.785.000 30.85%
2017 145.688.000 38.37%
2018 127.866.000 -13.94%
2019 173.611.000 26.35%
2020 143.364.000 -21.1%
2021 154.195.000 7.02%
2022 156.094.000 1.22%
2023 16.947.000 -821.07%
2023 85.551.000 80.19%
2024 18.884.000 -353.03%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Probi AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2012 1.102.000
2013 471.000 -133.97%
2014 3.823.000 87.68%
2015 1.238.000 -208.8%
2016 2.069.999 40.19%
2017 8.170.999 74.67%
2018 3.802.000 -114.91%
2019 26.731.000 85.78%
2020 30.036.000 11%
2021 35.147.000 14.54%
2022 52.429.000 32.96%
2023 7.164.000 -631.84%
2023 33.162.999 78.4%
2024 5.102.000 -550%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Probi AB (publ) Equity
Year Equity Growth
2012 122.816.000
2013 131.025.000 6.27%
2014 145.953.000 10.23%
2015 187.239.000 22.05%
2016 892.067.000 79.01%
2017 884.736.000 -0.83%
2018 1.028.397.999 13.97%
2019 1.152.126.000 10.74%
2020 1.115.203.000 -3.31%
2021 1.265.541.000 11.88%
2022 1.410.567.000 10.28%
2023 1.451.176.000 2.8%
2023 1.369.080.000 -6%
2024 1.426.132.000 4%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Probi AB (publ) Assets
Year Assets Growth
2012 136.728.000
2013 149.715.000 8.67%
2014 175.989.000 14.93%
2015 227.884.000 22.77%
2016 1.209.955.000 81.17%
2017 1.110.734.000 -8.93%
2018 1.209.430.000 8.16%
2019 1.289.608.000 6.22%
2020 1.239.893.000 -4.01%
2021 1.432.169.000 13.43%
2022 1.569.888.000 8.77%
2023 1.589.652.000 1.24%
2023 1.490.443.000 -6.66%
2024 1.537.135.000 3.04%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Probi AB (publ) Liabilities
Year Liabilities Growth
2012 12.770.000
2013 18.558.000 31.19%
2014 29.891.000 37.91%
2015 40.645.000 26.46%
2016 317.888.000 87.21%
2017 225.998.000 -40.66%
2018 174.260.000 -29.69%
2019 137.482.000 -26.75%
2020 124.690.000 -10.26%
2021 166.628.000 25.17%
2022 159.321.000 -4.59%
2023 138.476.000 -15.05%
2023 121.363.000 -14.1%
2024 111.003.000 -9.33%

Probi AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
53.32
Net Income per Share
-0.05
Price to Earning Ratio
-3842.22x
Price To Sales Ratio
3.81x
POCF Ratio
25.24
PFCF Ratio
36.73
Price to Book Ratio
1.62
EV to Sales
3.31
EV Over EBITDA
34.26
EV to Operating CashFlow
21.93
EV to FreeCashFlow
31.92
Earnings Yield
-0
FreeCashFlow Yield
0.03
Market Cap
2,31 Bil.
Enterprise Value
2,01 Bil.
Graham Number
12.2
Graham NetNet
30.32

Income Statement Metrics

Net Income per Share
-0.05
Income Quality
-152.24
ROE
-0
Return On Assets
-0
Return On Capital Employed
-0.01
Net Income per EBT
0.12
EBT Per Ebit
0.34
Ebit per Revenue
-0.02
Effective Tax Rate
-0.88

Margins

Sales, General, & Administrative to Revenue
0.1
Research & Developement to Revenue
0.08
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.32
Operating Profit Margin
-0.02
Pretax Profit Margin
-0.01
Net Profit Margin
-0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-24.6
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
8.04
Free CashFlow per Share
5.53
Capex to Operating CashFlow
-0.31
Capex to Revenue
-0.05
Capex to Depreciation
-0.32
Return on Invested Capital
-0.02
Return on Tangible Assets
-0
Days Sales Outstanding
42.54
Days Payables Outstanding
20.22
Days of Inventory on Hand
112.58
Receivables Turnover
8.58
Payables Turnover
18.06
Inventory Turnover
3.24
Capex per Share
-2.52

Balance Sheet

Cash per Share
29,84
Book Value per Share
125,16
Tangible Book Value per Share
64.92
Shareholders Equity per Share
125.16
Interest Debt per Share
3.24
Debt to Equity
0.03
Debt to Assets
0.02
Net Debt to EBITDA
-5.17
Current Ratio
8.07
Tangible Asset Value
0,74 Bil.
Net Current Asset Value
0,44 Bil.
Invested Capital
0.03
Working Capital
0,48 Bil.
Intangibles to Total Assets
0.45
Average Receivables
0,08 Bil.
Average Payables
0,03 Bil.
Average Inventory
121698500
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Probi AB (publ) Dividends
Year Dividends Growth
2020 1
2022 0 0%

Probi AB (publ) Profile

About Probi AB (publ)

Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.

CEO
Ms. Anita Johansen
Employee
167
Address
Ideongatan 1A
Lund, 223 70

Probi AB (publ) Executives & BODs

Probi AB (publ) Executives & BODs
# Name Age
1 Ms. Martina Pettersson
Global Marketing Director
70
2 Ms. Basudha Bhattarai-Johansson
Vice President of Human Relations & Sustainability
70
3 Mr. Per Lindblad
Chief Financial Officer
70
4 Ms. Veronica Dong
Head of APAC - Singapore
70
5 Ms. Magdolna Dimén
Group Controller
70
6 Ms. Anita Johansen
Chief Executive Officer
70
7 Mr. Jim Anthony
Interim Vice President of Operations
70
8 Ms. Karen Ong
Head of Asia-Pacific
70

Probi AB (publ) Competitors